91801-96-6

Basic information

• Product Name: α-bromophenylacetic acid N,N-diethylamide
• Synonyms: α-bromophenylacetic acid N,N-diethylamide
• CAS NO: 91801-96-6
• Molecular Weight: 270.169
• Mol File: 91801-96-6.mol

Chemical Properties

• CAS DataBase Reference: α-bromophenylacetic acid N,N-diethylamide(CAS DataBase Reference)
• NIST Chemistry Reference: α-bromophenylacetic acid N,N-diethylamide(91801-96-6)
• EPA Substance Registry System: α-bromophenylacetic acid N,N-diethylamide(91801-96-6)

Safety Data

• Hazardous Substances Data: 91801-96-6(Hazardous Substances Data)

Upstream product

• 4870-65-9 2-bromophenylacetic acid 
• 109-89-7 diethylamine 
• 19078-72-9 bromo(phenyl)acetyl chloride 

Downstream Products

• 32654-48-1 2-phenylsulfanyl-N,N-diethyl-2-phenylacetamide 
• 1388623-34-4 (S)-2-phenylsulfanyl-N,N-diethyl-2-phenylacetamide 
• 14790-34-2 α-Allyl-phenylessigsaeure-diethylamid 
• 1332709-02-0 N,N-diethyl-2-phenyl-2-(2,4,6-trimethoxyphenyl)acetamide 
• 14790-35-3 N,N-diethyl-4-methyl-2-phenylpent-4-enamide 
• 1094873-26-3 biphenyl-2-carboxylic acid (4-[4-(diethylcarbamoyl-phenyl-methyl)-piperazin-1-yl]-3-fluoro-phenyl)-amide 
• 1094873-13-8 2-[4-(4-nitro-2-fluoro-phenyl)-piperazin-1-yl]-N,N-diethyl-2-phenyl-acetamide 
• 136383-37-4 α-(diphenylphosphinyl)phenylacetic acid N,N-diethylamide 
• 1163246-31-8 2-(4-(5-diethylcarbamoyl(phenyl)methylpiperazin-1-yl)-3-fluorophenyl)-(S)-4,5-dihydrooxazole-4-carboxylic acid methyl ester 
• 1163246-29-4 N,N-diethyl-2-(4-(2-fluoro-4-(3-methyl-[1,2,4]oxadiazol-5-yl)phenyl)piperazin-1-yl)-2-phenylacetamide 
• 1163248-80-3 2-(4-(4-bromo-2-cyanophenyl)piperazin-1-yl)-N,N-diethyl-2-phenylacetamide 
• 1163245-96-2 N,N-diethyl-2-(4-(4-(5-ethyl-[1,2,4]oxadiazol-3-yl)-2-fluorophenyl)piperazin-1-yl)-2-phenylacetamide 
• 1163248-16-5 2-(4-(4-bromo-2-fluorophenyl)piperazin-1-yl)-N,N-diethyl-2-phenylacetamide 
• 935856-71-6 N,N-diethyl-2-[4-(2-fluoro-4-formyl-phenyl)-piperazin-1-yl]-2-phenyl-acetamide 

Relevant articles and documents

The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide y Y2 receptor

A series of small molecules based on a chemotype identified from our compound collection were synthesized and tested for binding affinity (IC 50) at the human Neuropeptide Y Y2 receptor (NPY Y 2). Six of the 23 analogs tes

Carbon-carbon bond-forming reactions of α-carbonyl carbocations: Exploration of a reversed-polarity equivalent of enolate chemistry

Carbon-carbon bond-forming reactions of putative α-carbonyl carbocation intermediates generated by Lewis acid- or silver-promoted ionizations of toluenesulfonate or halide leaving groups are described. This under-exploited mode of reactivity represents an 'umpolung' of conventional enolate chemistry, and enables C-C bond construction in both intra- and intermolecular contexts. Attempts to develop diastereoselective variants of this process using chiral ester and oxazolidinone-based auxiliaries are discussed.

PIPERAZINYL DERIVATIVES USEFUL AS MODULATORS OF THE NEUROPEPTIDE Y2 RECEPTOR

The present invention is directed to piperazinyl derivatives useful as inhibitors of the NPY Y2 receptor, pharmaceutical compositions comprising said compounds, processes for the preparation of said compounds and the use of said compounds for the treatment and / or prevention of disorders, diseases and conditions mediated by the NPY Y2 receptor.

SUBSTITUTED PIPERAZINES AND PIPERIDINES AS MODULATORS OF THE NEUROPEPTIDE Y2 RECEPTOR

The invention provides novel non-peptidic NPY Y2 receptor inhibitors useful in treating or preventing: anxiolytic disorders or depression; injured mammalian nerve tissue; conditions responsive to treatment through administration of a neurotrophic factor; neurological disorders; bone loss; substance related disorders; sleep/wake disorders; cardiovascular disease; obesity; or an obesity-related disorder. Compounds of the invention are also useful in modulating endocrine functions, particularly endocrine functions controlled by the pituitary and hypothalamic glands, and are therefore useful in the treatment or prevention of inovulation and infertility.